Common use of Facility Inspections Clause in Contracts

Facility Inspections. Serono shall, upon reasonable notice to Bioject, have the right to inspect the facilities in which the Products are manufactured, tested or stored at any time during the term of this Agreement and to observe the manufacture of the Products. Bioject shall consult with Serono prior to any response to the FDA or other regulatory authority relating to the Products, this Agreement or the manufacture of the Products. Bioject will promptly notify Serono of any FDA or other regulatory inspection related to the Products. Bioject will promptly notify Serono of the results of any such inspection and furnish Serono with a written description of actions taken, if any, to remedy conditions cited in any such inspection.